SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005398
Filing Date
2024-02-08
Accepted
2024-02-08 12:15:54
Documents
16
Period of Report
2024-02-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35440
2 ex99-1.htm EX-99.1 11912
3 ex99-1_001.jpg GRAPHIC 3743
  Complete submission text file 0001493152-24-005398.txt   231311

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE fblg-20240208.xsd EX-101.SCH 3033
5 XBRL LABEL FILE fblg-20240208_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE fblg-20240208_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3738
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41934 | Film No.: 24607850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)